0.67
-0.04(-5.63%)
Currency In GBp
Address
2 Blagrave Street
Reading, RG1 1AZ
United Kingdom of Great Britain and Northern Ireland
Phone
44 7490 391 888
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2
First IPO Date
June 28, 2004
| Name | Title | Pay | Year Born |
| Mr. Ian Ford BA (Hons) ACA, F.C.A. | Chief Executive Officer, Chief Financial Officer, Company Secretary & Executive Director | 168,749 | 1965 |
| Dr. Niamh Ann O'Kennedy B.Sc., BSc, M.Sc., MSc, Ph.D. | Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director | 94,109 | 1973 |
| Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN | Consultant & Member of Scientific Advisory Board | 0 | N/A |
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.